Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02029833 · ClinicalTrials.gov registry record · NA
Canola Oil Multi-Centre Intervention Trial II
A NA study of Diabetes and Cardiovascular Disease, sponsored by University of Manitoba.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 4
- Study locations
NCT02029833: Completed NA study of Diabetes and Cardiovascular Disease, sponsored by University of Manitoba.
NCT02029833 is a NA study of Diabetes and Cardiovascular Disease that has completed, run by University of Manitoba. The registered enrollment target is 125 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02029833, a NA study of Diabetes and Cardiovascular Disease, has completed, sponsored by University of Manitoba.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 4
- Study locations
Study Summary
The objectives of the study are to examine the health benefits of dietary canola oils on body composition, specifically on android fat, and weight management. COMIT II will also include analysis of FAEs to elucidate the mechanisms by which canola oil may be modifying body composition. Measurement of endothelial function, inflammatory, adiposity, and insulin sensitivity biomarkers will be done to determine the positive health impact of the changes in body composition achieved through canola oil consumption.
Primary Outcome
Using a Dual Energy X-Ray Absorptiometry machine to analyze body composition, including measuring visceral adiposity. Units (fat mass) measured are cm3 and lbs.
Conditions Studied
Interventions
- OTHER Regular Canola Oil
- OTHER High Oleic Canola Oil
- OTHER Western Type Diet - Common Dietary Oils
Study Locations (4)
Manitoba
- St Boniface Hospital Research - Winnipeg
- Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba - Winnipeg
Pennsylvania
- The Pennsylvania State University - University Park
Quebec
- Institute of Nutrition and Functional Foods, Laval University - Québec
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT02029833 record still lists
NCT02029833 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Regular Canola Oil is the first listed.
NCT02029833 reports a single indexed study location in Manitoba, Pennsylvania, Quebec.
Frequently Asked Questions
What is clinical trial NCT02029833 about?
NCT02029833 is a clinical study titled "Canola Oil Multi-Centre Intervention Trial II". The objectives of the study are to examine the health benefits of dietary canola oils on body composition, specifically on android fat, and weight management. COMIT II will also include analysis of FAEs to elucidate the mechanisms by which canola oil may be modifying body composition. Measurement of...
What is the current status of trial NCT02029833?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2013-03. Estimated completion is 2016-11.
What conditions does trial NCT02029833 study?
This clinical trial studies the following conditions: Diabetes, Cardiovascular Disease, Metabolic Syndrome.
What interventions are being tested in trial NCT02029833?
The interventions under investigation include: Regular Canola Oil (OTHER), High Oleic Canola Oil (OTHER), Western Type Diet - Common Dietary Oils (OTHER).
Who is sponsoring clinical trial NCT02029833?
This trial is sponsored by University of Manitoba, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02029833 being conducted?
This trial has 4 study locations across Pennsylvania, Manitoba, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02029833's enrollment target sits among peer trials
125 180th of 338 higher than 159 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia